They fundamentally reshape the environment inside your gut, from the speed of digestion to the bacteria that live there
A similar beneficial association was seen in an observational study of semaglutide in 83,825 patients with obesity and 598,803 patients with T2DM over 12 months 112 , as well as in 87,676 new users of GLP-1RAs or DPP-4 inhibitors over 4 years 113
There are no data to support these claims. What Are GLP-1 Patches
Cardiovascular outcomes, long-term efficacy and safety In people with T2D and established cardiovascular disease, the international guidelines for T2D recommend the use of GLP-1 RA or sodium glucose co-transporters 2 inhibitors (SGLT-2i) as first-line treatment (independent of HbA1c), based on multiple trials demonstrating their cardio-renal benefits [109]
Iron deficiency anemia Beyond low ferritin, actual iron deficiency anemia causes more severe and persistent hair loss